BrainSpec Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

BrainSpec General Information

Description

Developer of a medical diagnostic platform designed to make virtual biopsy a reality. The company's platform uses magnetic resonance spectroscopy to diagnose a wide range of neurological disorders and traumatic brain injuries in a completely non-invasive manner, enabling physicians to access data from anywhere, any time, on any device, reducing case processing time and leading to enhanced output at decreased costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 665 Washington Street
  • Suite 2410
  • Boston, MA 02111
  • United States
+1 (617)
Primary Industry
Biotechnology
Other Industries
Decision/Risk Analysis
Drug Discovery
Corporate Office
  • 665 Washington Street
  • Suite 2410
  • Boston, MA 02111
  • United States
+1 (617)

BrainSpec Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BrainSpec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Generating Revenue
8. Later Stage VC 21-Aug-2023 Completed Generating Revenue
7. Accelerator/Incubator 12-Jul-2023 Completed Generating Revenue
6. Accelerator/Incubator 04-Apr-2022 Completed Generating Revenue
5. Seed Round 25-Sep-2017 Completed Generating Revenue
4. Accelerator/Incubator 07-Feb-2017 Completed Generating Revenue
3. Grant 05-May-2016 Completed Generating Revenue
2. Grant 14-Apr-2016 $100K Completed Generating Revenue
1. University Spin-Out 01-May-2015 Completed Startup
To view BrainSpec’s complete valuation and funding history, request access »

BrainSpec Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view BrainSpec’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BrainSpec Patents

BrainSpec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021108718-A1 Systems and methods for analyzing and interfacing with combined imaging and spectroscopy data for the brain Inactive 27-Nov-2019
US-12551107-B2 Systems and methods of analyzing and interfacing with combined imaging and spectroscopy data for the brain Active 27-Nov-2019
US-20210169332-A1 Systems and methods of analyzing and interfacing with combined imaging and spectroscopy data for the brain Active 27-Nov-2019
US-20260272302-A1 Systems and methods of analyzing and interfacing with combined imaging and spectroscopy data for the brain Pending 27-Nov-2019 A61B5/0042

BrainSpec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BrainSpec Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bacchus Venture Capital Angel Group Minority
Creative Destruction Lab Accelerator/Incubator
University of Toronto University
DCVC Venture Capital Minority
Techstars Accelerator/Incubator Minority
You’re viewing 5 of 9 investors. Get the full list »

BrainSpec FAQs

  • When was BrainSpec founded?

    BrainSpec was founded in 2015.

  • Where is BrainSpec headquartered?

    BrainSpec is headquartered in Boston, MA.

  • What is the size of BrainSpec?

    BrainSpec has 10 total employees.

  • What industry is BrainSpec in?

    BrainSpec’s primary industry is Biotechnology.

  • Is BrainSpec a private or public company?

    BrainSpec is a Private company.

  • What is BrainSpec’s current revenue?

    The current revenue for BrainSpec is .

  • How much funding has BrainSpec raised over time?

    BrainSpec has raised $1.97M.

  • Who are BrainSpec’s investors?

    Bacchus Venture Capital, Creative Destruction Lab, University of Toronto, DCVC, and Techstars are 5 of 9 investors who have invested in BrainSpec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process